Search results
All genres
Meeting Abstract (45)
2018
Meeting Abstract
Highly efficient influenza virus production: A MDCK-based high-cell-density process. In Vaccine Technology VII, 13. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Orbital shaken bioreactor for influenza A virus production in high cell density cultivations. In Vaccine Technology VII, 40. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Continuous purification of cell culture-derived influenza A virus particles through pseudo- affinity membrane chromatography. In Vaccine Technology VII, 124. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
A new porcine suspension cell line (PBG.PK-21) provides efficient production for influenza and yellow fever vaccine viruses. In Vaccine Technology VII, 48. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Single-cell analysis uncovers a novel influenza A virus-derived defective interfering particle for antiviral therapy. In Vaccine Technology VII, 133. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates. In Vaccine Technology VII, 128. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Flavivirus production in perfusion processes using the EB66® cell line. In Vaccine Technology VII, 80. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Addressing the challenges of influenza virus-like particles purification. In Vaccine Technology VII, 57. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Influenza virus capture using membrane chromatography: Improving selectivity by matrix design and pseudo-affinity ligand interactions. In Vaccine Technology VII, 75. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Efficient influenza vaccine manufacturing: Single MDCK suspension cells in chemically defined medium. In Vaccine Technology VII, 5. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
2017
Meeting Abstract
Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccines. In ECI Symposium Series. Integrated Continuous Biomanufacturing III, Cascais, Portugal, September 17, 2017 - September 21, 2017. (2017)
2016
Meeting Abstract
Pseudo-affinity purification and formulation of a cell-culture derived whole influenza virus vaccine using magnetic sulfated cellulose particles. In Vaccine Technology VI, 57. Vaccine Technology VI, Albufeira, Portugal, June 12, 2016 - June 17, 2016. (2016)
2015
Meeting Abstract
32 (5), p. 321 - 321. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
IgCarbKB: a glycomics and glycoproteomics focused immunoglobulin knowledge base. In Glycoconjugate Journal,
Meeting Abstract
32 (5), p. 206 - 206. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
Unraveling The N-glycosylation Of Induced Pluripotent Stem Cells From A PMM2-CDG Patient. In Glycoconjugate Journal,
Meeting Abstract
32 (5), p. 324 - 324. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
The sweet characterization of therapeutic protein N-glycosylation using xCGE-LIF. In Glycoconjugate Journal,
Meeting Abstract
32 (5), p. 293 - 293. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
The Sweet Side of Neurons–xCGE-LIF Based Structural Characterization of Neuron and Synaptic N-GlycansComposition. In Glycoconjugate Journal,
Meeting Abstract
Human blood plasma O-glycoproteomics. In Glycoconjugate Journal, (5), pp. 324 - 325. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
Meeting Abstract
32 (5), p. 290 - 290. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
Region-specific N-glycan mapping in inflammatory bowel disease and control tissue using PGC-LC-ESI-MS/MS. In Glycoconjugate Journal, 2011
Meeting Abstract
5 (S8), P47. 22nd European Society for Animal Cell Technology (ESACT) - Meeting on Cell Based Technologies
, Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)
Criteria for bioreactor comparison and operation standardisation during process development for mammalian cell culture. In BMC Proceedings,
Meeting Abstract
28 (5 ), p. 332. 21st International Symposium on Glycoconjugates - Glyco 21, Wien, Östereich, August 21, 2011 - August 26, 2011. (2011)
Tailored methods for CGE-LIF based multiplexed high-throughput glycoanalysis with respect to sample characteristics. In Glycoconjugate Journal,